down arrow

Caplin Point Lab

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE475E01026
  • NSEID: CAPLIPOINT
  • BSEID: 524742
INR
1,829.95
114.95 (6.7%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.98 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 640544,
    "name": "Caplin Point Lab",
    "stock_name": "Caplin Point Lab",
    "full_name": "Caplin Point Laboratories Ltd",
    "name_url": "stocks-analysis/caplin-point-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,829.95",
    "chg": 114.95,
    "chgp": "6.7%",
    "dir": 1,
    "prev_price": "1,715.00",
    "mcapval": "13,909.76 Cr",
    "mcap": "Mid Cap",
    "scripcode": 524742,
    "symbol": "CAPLIPOINT",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE475E01026",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "22:58 PM",
    "bse_nse_vol": "2.98 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caplin-point-lab-640544-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Caplin Point Laboratories Shows Trend Reversal Amid High Volatility and Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-gains-6-0-amid-sector-recovery-and-high-volatility-1693333",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/CaplinPointLabo_priceRelatedfactors_882929.png",
        "date": "2025-04-03 09:30:32",
        "description": "Caplin Point Laboratories experienced notable activity on April 3, 2025, reversing a three-day decline with a significant intraday high. The stock demonstrated high volatility and outperformed both the pharmaceuticals sector and the broader market. Over the past month, it has shown strong gains, while its long-term growth remains impressive."
      },
      {
        "title": "Caplin Point Laboratories Shows Mixed Technical Trends Amid Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-volatility-1670549",
        "imagepath": "",
        "date": "2025-04-02 08:05:52",
        "description": "Caplin Point Laboratories, a midcap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1981.95, slightly down from the previous close of 1987.55. Over the past year, Caplin Point has demonstrated a notable performance, with a return of 44.37%, significantly outpacing the Sensex's 2.72% return during the same period.\n\nIn terms of technical indicators, the weekly MACD and KST are showing mildly bearish trends, while the monthly indicators also reflect a similar sentiment. The Bollinger Bands present a mixed picture, indicating bearish conditions on a weekly basis but mildly bullish on a monthly scale. Moving averages suggest a mildly bullish stance on a daily basis, although the overall trend remains neutral according to Dow Theory.\n\nCaplin Point's performance over various time frames highlights i..."
      },
      {
        "title": "Caplin Point Laboratories Shows Strong Performance Amid Broader Market Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-stock-rises-5-14-amid-broader-market-gains-1215679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/CaplinPointLabo_priceRelatedfactors_598166.png",
        "date": "2025-03-06 10:20:23",
        "description": "Caplin Point Laboratories has experienced significant activity, gaining 5.14% on March 6, 2025, and outperforming its sector. The stock has shown consecutive gains over three days, with a total return of 12.55%. In the broader market, the Sensex opened higher but remains near its 52-week low."
      },
      {
        "title": "Caplin Point Laboratories Shows Trend Reversal Amid Broader Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-gains-5-62-after-six-days-of-decline-shows-high-volatility-1184417",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/CaplinPointLabo_priceRelatedfactors_573972.png",
        "date": "2025-03-04 14:35:21",
        "description": "Caplin Point Laboratories has seen a significant rebound today after a six-day decline, reaching an intraday high amid notable volatility. Despite this uptick, the stock remains below key moving averages and has experienced declines over the past week and month, though it has gained over the past year. The broader market, represented by the Sensex, is also facing challenges."
      },
      {
        "title": "Caplin Point Laboratories Faces Continued Stock Decline Amid Sector Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-stock-declines-5-62-underperforming-sector-and-market-1172150",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/CaplinPointLabo_priceRelatedfactors_562367.png",
        "date": "2025-03-03 10:15:46",
        "description": "Caplin Point Laboratories has faced a notable decline in its stock performance, falling for six consecutive days and experiencing a significant drop over the past month. The company's shares are currently trading below key moving averages, highlighting ongoing challenges in the pharmaceuticals sector."
      },
      {
        "title": "Caplin Point Laboratories Faces Sustained Decline Amid Broader Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-stock-declines-5-03-underperforming-sector-and-market-indices-1142589",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/CaplinPointLabo_priceRelatedfactors_551144.png",
        "date": "2025-02-28 12:35:20",
        "description": "Caplin Point Laboratories has faced a significant decline in its stock price, underperforming compared to the broader Pharmaceuticals & Drugs sector. The stock has recorded losses for five consecutive days and is trading below key moving averages, reflecting ongoing challenges in the current market environment."
      },
      {
        "title": "Caplin Point Laboratories Shows Strong Performance Amidst Market Volatility in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-stock-rises-5-03-outperforming-sector-on-february-19-2025-1057180",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/CaplinPointLabo_priceRelatedfactors_472070.png",
        "date": "2025-02-19 15:05:23",
        "description": "Caplin Point Laboratories experienced significant trading activity, outperforming its sector and the Sensex on February 19, 2025. The stock's performance showed short-term strength, although it faced challenges over the past month, reflecting the volatility inherent in the pharmaceutical industry."
      },
      {
        "title": "Caplin Point Laboratories Faces Continued Stock Decline Amid Market Volatility in February 2025",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-stock-declines-5-11-amid-broader-market-downturn-in-february-2025-1012320",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/CaplinPointLabo_priceRelatedfactors_449604.png",
        "date": "2025-02-14 13:45:44",
        "description": "Caplin Point Laboratories has seen a significant decline in its stock price, dropping for two consecutive days and experiencing an 18.30% decrease over the past month. The company's performance has lagged behind its sector, reflecting ongoing volatility and challenges in the current market environment."
      },
      {
        "title": "Caplin Point Laboratories Faces Intraday Volatility Amid Broader Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-stock-declines-5-07-amid-notable-intraday-volatility-914108",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/CaplinPointLabo_priceRelatedfactors_397189.png",
        "date": "2025-02-10 12:05:18",
        "description": "Caplin Point Laboratories has faced notable stock volatility on February 10, 2025, with significant intraday fluctuations. The stock opened positively but quickly reversed, reflecting mixed short-term performance. Over the past month, it has declined substantially, contrasting with the broader market's minor decrease, indicating ongoing challenges for the company."
      }
    ],
    "total": 120,
    "sid": "640544",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/caplin-point-laboratories-640544"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "03-Apr-2025",
      "details": "Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2025 is enclosed.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "02-Apr-2025",
      "details": "Caplin Point Laboratories Limited informed that the Board of Directors of Caplin Point Far East Limited Hong Kong a material subsidiary of the Company had approved the investment in Neoethicals Chile SpA.",
      "source": "BSE"
    },
    {
      "caption": "Cautionary Letter From NSE And BSE On March 28 2025",
      "datetime": "29-Mar-2025",
      "details": "Enclosing a copy of cautionary e-mail received from National Stock Exchange of India Limited and BSE Limited with respect to the intimation of Schedule of Investors/ Analysts Meet/ Call on August 30 2024.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has declared <strong>125%</strong> dividend, ex-date: 23 Sep 24",
          "dt": "2024-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16",
          "dt": "2016-10-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

03-Apr-2025 | Source : BSE

Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2025 is enclosed.

Announcement under Regulation 30 (LODR)-Acquisition

02-Apr-2025 | Source : BSE

Caplin Point Laboratories Limited informed that the Board of Directors of Caplin Point Far East Limited Hong Kong a material subsidiary of the Company had approved the investment in Neoethicals Chile SpA.

Cautionary Letter From NSE And BSE On March 28 2025

29-Mar-2025 | Source : BSE

Enclosing a copy of cautionary e-mail received from National Stock Exchange of India Limited and BSE Limited with respect to the intimation of Schedule of Investors/ Analysts Meet/ Call on August 30 2024.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Caplin Point Laboratories Ltd has declared 125% dividend, ex-date: 23 Sep 24

stock-summary
SPLITS

Caplin Point Laboratories Ltd has announced 2:10 stock split, ex-date: 19 Oct 16

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available